Hence, it is proposed that the identified compounds are pharmacologically active in rooibos tea and could modulate the activation of HIF-1 genes of the HIF-1 signaling pathway implicated in T2DM. The gene discussed is HIF1A; the disease is type 2 diabetes mellitus.